# Amphastar Nanjing Pharmaceuticals Inc – FDA Inspection, Sep 19, 2025

Source: https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/8c11e7e8-9c3d-43fb-940f-6748a59595b1
Source feed: FDA_Inspections

> FDA inspection 1291882 of Amphastar Nanjing Pharmaceuticals Inc, September 19, 2025. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291882
- Company Name: Amphastar Nanjing Pharmaceuticals Inc
- Inspection Date: 2025-09-19
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1269036 - 2025-03-07
- FDA Inspection 1107981 - 2019-10-11
- FDA Inspection 1036696 - 2017-10-26
- [FDA Inspection 1017547 - 2017-04-28](https://www.keypedia.com/records/fda_inspections/amphastar-nanjing-pharmaceuticals-inc/4fc6bd5e-2e76-4169-ba5f-13b6dada7297)
- FDA Inspection 969870 - 2016-04-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/doan-n-singh/e52cfbca-5710-4765-8c5e-d534946b648d)
- [Issuing Officer](https://www.keypedia.com/people/duan-singh/8f6e0c84-e1d4-4ce6-8b91-9f2e3f641155)
- [Issuing Officer](https://www.keypedia.com/people/tamanna-azam/0fe21912-a62e-4606-9451-e0777090bfee)
- [Xiaoshi Wang](https://www.keypedia.com/people/xiaoshi-wang/8249ff14-dec6-4ffd-9893-bdf8ba6af7ce)

Company: https://www.keypedia.com/companies/amphastar-nanjing-pharmaceuticals-inc/ad29710e-4137-4608-933e-8292394dcbc7

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
